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Infection of adult 129 Sv/Ev mice with consensus Sindbis virus strain TR339 is subclinical due to an inherent
restriction in early virus replication and viremic dissemination. By comparing the pathogenesis of TR339 in
129 Sv/Ev mice and alpha/beta interferon receptor null (IFN-a/bR2/2) mice, we have assessed the contribution
of IFN-a/b in restricting virus replication and spread and in determining cell and tissue tropism. In adult 129
Sv/Ev mice, subcutaneous inoculation with 100 PFU of TR339 led to extremely low-level virus replication and
viremia, with clearance under way by 96 h postinoculation (p.i.). In striking contrast, adult IFN-a/bR2/2 mice
inoculated subcutaneously with 100 PFU of TR339 succumbed to the infection within 84 h. By 24 h p.i. a
high-titer serum viremia had seeded infectious virus systemically, coincident with the systemic induction of the
proinflammatory cytokines interleukin-12 (IL-12) p40, IFN-g, tumor necrosis factor alpha, and IL-6. Repli-
cating virus was located in macrophage-dendritic cell (DC)-like cells at 24 h p.i. in the draining lymph node
and in the splenic marginal zone. By 72 h p.i. virus replication was widespread in macrophage-DC-like cells in
the spleen, liver, lung, thymus, and kidney and in fibroblast-connective tissue and periosteum, with sporadic
neuroinvasion. IFN-a/b-mediated restriction of TR339 infection was mimicked in vitro in peritoneal exudate
cells from 129 Sv/Ev versus IFN-a/bR2/2 mice. Thus, IFN-a/b protects the normal adult host from viral
infection by rapidly conferring an antiviral state on otherwise permissive cell types, both locally and system-
ically. Ablation of the IFN-a/b system alters the apparent cell and tissue tropism of the virus and renders
macrophage-DC-lineage cells permissive to infection.
The prototypic alphavirus, Sindbis virus strain AR339, was
isolated by intracerebral (i.c.) inoculation of 3-day-old mice
with a mosquito homogenate collected near Sindbis, Egypt
(59). The laboratory animal model for natural Sindbis virus
infection and pathogenesis is the mouse, inoculated subcuta-
neously (s.c.) to mimic transmission by the bite of an infected
mosquito. In experimental mouse infections, Sindbis virus rep-
licates primarily in skin, fibroblast connective tissue, and mus-
cle, causing a myositis. Virus spreads systemically via a serum
viremia and seeds the central nervous system (CNS) (24).
However, the severity of Sindbis virus infection under different
conditions can range from uniformly fatal to subclinical, with a
concurrent decrease in mortality rate and extension of average
survival time (AST; reviewed in reference 26). The outcome of
infection is heavily dependent upon a number of parameters,
including (i) the age of the host when inoculated (e.g., refer-
ences 18, 20, 25, 47, 59, 60), (ii) the genotype of the virus (e.g.,
references 29, 32, 44, 45, 54, 61), and (iii) the inoculum dose
administered (e.g., reference 34). All Sindbis virus strains are
avirulent in adult mice regardless of the dose or route of
inoculation, except for those strains that have been neuroad-
apted by extensive passage in the mouse CNS (32, 62). Al-
though the basis for Sindbis virus virulence has not been fully
elucidated, attenuation of virulence typically correlates with
reduced virus replication and potential for dissemination,
rather than an altered tissue tropism or differential ability of
the host to clear virus (18, 29, 60, 61). These data suggest that
the innate immune system may play a role in determining the
relative permissivity of host tissues to virus infection under
different circumstances.
The alpha/beta interferon (IFN-a/b) system is an important
component of the host’s first line of defense against virus
infections (reviewed in references 14 and 25). In vitro, Sindbis
virus is particularly sensitive to the antiviral effects of IFN-a/b
(41, 43). However, in vivo the extent of IFN-a/b induction
parallels the level of virus replication (29, 47, 54, 60, 61, 64).
Thus, the amount of IFN-a/b induced in a fatal neonatal in-
fection far exceeds the induction during a subclinical adult
infection (60, 64). Consequently, investigation into the role of
IFN-a/b in Sindbis virus pathogenesis has been limited to two
studies demonstrating that neutralization of IFN-a/b by anti-
serum increased susceptibility to Sindbis virus infection (61; G.
Cole, E. Johnson, A. Schmaljohn, and I. Gresser, Abstr. Fifth
Int. Congr. Virol. 1981, abstr. P06/05, p. 97).
In this study, we have reexamined the hypothesis that this
innate antiviral defense mechanism is critical in limiting Sind-
bis virus infection in vivo. The tools for investigating this hy-
pothesis thoroughly have become available relatively recently.
First, genetically modified mice have been generated with a
deficient IFN-a/b system by interrupting the gene encoding the
known receptor subunit (37). These IFN-a/b receptor null
(IFN-a/bR2/2) mice are completely unresponsive to extracel-
lular IFN-a/b and are very susceptible to infection with a
number of viruses (12, 13, 17, 22, 36, 37, 57), including two
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other alphaviruses, Semliki Forest virus (SFV) (22, 37) and
Venezuelan equine encephalitis virus (VEE) (17). Second,
identification of cell culture-adaptive mutations in laboratory
Sindbis virus strains (34) has permitted the construction of an
infectious clone eliminating known adaptive mutations (28).
The virus derived from this clone, designated TR339, repro-
duces as closely as possible the original AR339 Sindbis virus
isolate, does not exhibit cell culture-adaptive heparan sulfate
(HS) binding, and is more virulent for neonatal mice than cell
culture-adapted, laboratory Sindbis virus strains (28, 29). Com-
parison of Sindbis virus TR339 pathogenesis in mice with or
without a functional IFN-a/b system has allowed us to study
several aspects of the interplay between the host’s nonspecific
immune response and the infecting virus, including (i) the
importance of IFN-a/b in the protection of adult mice from
fatal Sindbis virus infection, (ii) the role of IFN-a/b protection
in attenuation of HS-binding glycoprotein mutants, (iii) the
relevance of the IFN-a/b system to age-dependent resistance
to Sindbis virus infection, and (iv) the effect of ablating the
IFN-a/b system on the apparent cell and tissue tropism of
Sindbis virus in vivo.
MATERIALS AND METHODS
Virus. Baby hamster kidney cells (BHK-21; ATCC CCL-10) were maintained
in alpha-minimal essential medium supplemented with 10% donor calf serum
(DCS), 2.9 mg of tryptose phosphate per ml, 0.29 mg of L-glutamine per ml, 100
U of penicillin per ml, and 0.05 mg of streptomycin per ml (37°C, 5% CO2).
Infectious viral RNA was transcribed in vitro from linearized cDNA templates of
the full-length viral genome and transfected into BHK-21 cells by electropora-
tion. Virus particles were harvested from the supernatant 18 to 20 h after
electroporation, clarified by centrifugation (1,500 3 g, 4°C, 30 min), and stored
at 270°C in single-use aliquots. To minimize the accumulation of tissue culture-
adaptive mutations in virus stocks, only high-efficiency electroporations causing
complete cytopathic effect were used. Virus stocks were not passed further prior
to use. Titers of virus stocks were determined by standard BHK-21 cell plaque
assay, and titers were expressed as PFU per milliliters. For routine mouse
inoculations, a virus stock aliquot was diluted into low-endotoxin phosphate-
buffered saline supplemented with 1% DCS (PBS–1% DCS). Single-use aliquots
of diluted virus were stored at 270°C, and the titer of one thawed aliquot was
confirmed by plaque assay. To concentrate virus for high-dose inoculations,
clarified virus preparations were purified by pelleting through 20% sucrose in
TNE (0.05 M Tris-HCl, 0.15 M NaCl, 0.001 M EDTA buffer [pH 7.2]; 100,000 3
g, 4°C, 5 h). The virus pellet was allowed to swell overnight in PBS–1% DCS
before resuspension and then filtered through a 0.2-mm (pore-size) filter. The
virus titer was confirmed by plaque assay.
In vitro growth curves. Peritoneal exudate cells were collected by peritoneal
lavage of cervically dislocated mice. A 10-ml portion of RPMI 1640 medium was
injected intraperitoneally (i.p.) by using a 10-ml syringe and a 25-gauge needle,
and the abdomen of the mouse was agitated. Lavage fluids were collected by
using a 10-ml syringe and 18-gauge needle, and cells were pelleted by centrifu-
gation (60 3 g, 4°C, 8 min). Cells were resuspended in RPMI 1640 medium
supplemented with 10% fetal bovine serum and 2.9 mg of tryptose phosphate,
0.29 mg of L-glutamine, 100 U of penicillin, and 0.05 mg of streptomycin per ml
and then seeded into 24-well plates (approximately 2 3 104 cells/well). After 24 h
of incubation (37°C, 5% CO2) cells were washed with PBS–1% DCS and infected
at a multiplicity of infection (MOI) of 10 in a 0.2-ml volume (37°C, 1 h). Cells
were washed three times with PBS–1% DCS, and either 1 ml of medium alone
or medium supplemented with ca. 8,000 neutralizing U of anti-IFN-a/b antibody
(Lee Biomolecular) was added. Virus was titrated from the supernatant over a
48-h time course.
Mice. Breeder pairs of IFN-a/bR1/1 129 Sv/Ev and IFN-a/bR2/2 mice were
kindly provided by Herbert Virgin (Washington University, Saint Louis, Mo.)
and Barbara Sherry (North Carolina State University, Raleigh, N.C.), respec-
tively. Mice were bred in the Department of Laboratory Animal Medicine breed-
ing colony facilities at the University of North Carolina at Chapel Hill under
specific-pathogen-free conditions. Cross-breeding male 129 Sv/Ev mice with fe-
male IFN-a/bR2/2 mice generated mice heterozygous for the IFN-a/b receptor
(IFN-a/bR1/2). Procedures were carried out in accordance with institutional
guidelines for animal care and use.
Mouse procedures. For routine mouse inoculations, randomized groups of
mice were inoculated with 100 PFU of virus in a 50-ml volume (2 3 103 PFU/ml).
The inoculum was administered s.c. in the ventral thorax by using a 27-gauge
needle and a 1-ml hypodermic syringe. Mock-infected mice received 50 ml of
PBS–1% DCS by the same route. For high-dose inoculations, concentrated virus
was inoculated s.c. as described above. All surviving mice were challenged i.c.
with S.A.AR 86 virus, which causes 100% mortality in naive adult mice when
administered by this route (56). Mice were metofane-anesthetized (Schering-
Plough Animal Health), and 1,000 PFU of S.A.AR 86 in a 10-ml volume was
inoculated i.c. at the suture by using a 27-gauge needle and 100-ml Hamilton
syringe. Blood was collected from the tail vein, and serum was separated by
centrifugation in microtainer tubes (Becton Dickinson) according to manufac-
turer’s instructions and stored at 270°C prior to use.
Mortality studies. Virus-infected and mock-infected mice were observed at
6-h intervals and scored for the degree of morbidity, AST, and percent mortality.
Serum collected from surviving mice at 3 weeks postinoculation (p.i.) was as-
sayed for the presence of virus by BHK plaque assay and for anti-Sindbis virus
antibody by enzyme-linked immunosorbent assay (ELISA) by using mock-in-
fected mice as controls. The surviving mice were then challenged i.c. with
S.A.AR 86 virus as described above.
Pathogenesis studies. The thoracic cavity of each mouse was opened under
metofane anesthesia, and blood was collected by cardiac puncture. Serum was
separated from whole blood by using microtainer tubes, aliquoted, and stored at
270°C. Each mouse was then perfused with PBS–1% DCS at a rate of 7 ml/min
for 15 to 20 min to flush out the blood-associated virus. Tissues were harvested
into preweighed Kontes tissue homogenization tubes, and PBS–1% DCS was
added to result in 33% (brain) or 10% (all other tissues) suspensions. Tissues
were homogenized by one freeze-thaw and mechanical disruption and then
clarified by centrifugation. Tissue supernatants and serum were assayed for virus
by BHK plaque assay.
Cytokine assays. Titers of IFN-a/b in serum were determined by standard
biological assay on L929 cells by using a commercially prepared IFN-a/b stan-
dard (Lee Biomolecular) and encephalomyocarditis virus (EMCV) as the indi-
cator virus as described previously (61). The end point was defined as the dilution
of IFN-a/b required to protect 50% of the cells from EMCV-induced cytopathic
effect, and the level of IFN-a/b was expressed as IU per milliliters. Serum levels
of the proinflammatory cytokines interleukin-12 (IL-12) p40, tumor necrosis
factor alpha (TNF-a), IFN-g, and IL-6 were determined by sandwich ELISA as
described previously (39, 40, 50).
Histology. Under metofane anesthesia, mice were perfused with 4% parafor-
maldehyde in PBS (PFA, pH 7.4). Whole PFA-perfused mice were fixed in 4%
PFA for one additional week and then decalcified in 4% PFA–8% EDTA (pH
6.8, 4°C) for up to 6 weeks. Tissues were paraffin embedded and sectioned at
5-mm thicknesses. Hematoxylin and eosin (H&E)-stained sections were viewed
by light microscopy.
ISH. In situ hybridization (ISH) analyses to detect viral genomic RNA were
performed as described previously (16). Radiolabeled riboprobes were generated
by in vitro transcription from linearized plasmid DNA in the presence of
[a-35S]UTP (Amersham). Riboprobe complementary to a region in the sub-
genomic viral RNA was generated from plasmid pGSV.SS (61). Riboprobe
complementary to a region in the EBER2 protein gene of Epstein-Barr virus and
tissue sections from mock-infected mice controlled for nonspecific probe hybrid-
ization. Sections were counterstained with hematoxylin and viewed by light
microscopy.
IHC. Immunohistochemistry (IHC) was performed essentially as described
previously (33). Mice were sacrificed by cervical dislocation under anesthesia.
Dissected tissues were embedded in OCT Compound (Tissue-Tek) and imme-
diately snap-frozen to avoid ischemic changes. Fresh-frozen sections were cut at
approximately 10-mm thicknesses and acetone fixed. Prior to IHC staining, sec-
tions were washed in PBS to remove OCT Compound and blocked with 10%
normal goat serum. Sections were incubated overnight with a 1:4,000 dilution of
polyclonal rabbit anti-Sindbis virus serum or normal rabbit serum control. De-
tection was achieved with a goat anti-rabbit CY2-conjugated secondary antibody.
Double staining to colocalize antigens was performed by incubating anti-Sindbis
virus stained sections for 1 h with antibody to cell surface markers: DEC-205 (rat
anti-mouse NLDC-145, 0.5 mg/ml; American Type Culture Collection [ATCC]),
CD11c (hamster anti-mouse N418, 0.3 mg/ml; ATCC), CD11b (rat anti-mouse
Mac-1, 3 mg/ml; kindly provided by Herbert Virgin, Washington University, Saint
Louis, Mo.), F4/80 (rat anti-mouse, 1 mg/ml; ATCC), or CD45 (biotinylated
anti-mouse B220, 0.5 mg/ml; Pharmingen) alongside sections stained with iso-
type-matched control antibody. Antibody binding was detected with an appro-
priate Texas red-conjugated secondary antibody. Sections were viewed on a
Nikon inverted fluorescence microscope by using fluorescein isothiocyanate
(FITC), Texas red, and triple-pass filters.
RESULTS
Virulence of consensus Sindbis virus strain TR339 in adult
mice. Sindbis virus infection of mice is characterized by an
age-dependent attenuation of virulence. Neonatal mice suc-
cumb to fatal infection with less than 1 PFU of virus, whereas
adult mice are uniformly resistant to very high virus doses. As
an initial experiment to investigate the role of the IFN-a/b
system in protection from Sindbis virus-induced disease, the
virulence of TR339 was tested in age-matched, adult (5 to 7
week old) homozygous IFN-a/bR2/2 mice, heterozygous IFN-
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a/bR1/2 mice, and congenic background IFN-a/bR1/1 129
Sv/Ev mice. Mice were inoculated s.c. in the ventral thorax with
100 PFU of TR339 and then scored at 6-h intervals for mor-
bidity (visually and by weight measurement) and mortality.
Data from a representative experiment are shown in Table 1.
As expected, infection of adult, IFN-a/bR1/1 129 Sv/Ev mice
with TR339 was subclinical, with no morbidity or coincident
weight loss during the 3-week observation period. At 3 weeks
p.i. TR339-infected 129 Sv/Ev mice had elicited a virus-specific
antibody response and were completely protected from i.c.
challenge with a related neurovirulent alphavirus, S.A.AR 86,
with no morbidity observed (Table 1). S.A.AR 86 is a member
of the Sindbis group of alphaviruses, but it is more closely
related to Girdwood and Okelbo than to Sindbis AR339 and is
neurovirulent in adult mice following i.c. inoculation (56).
Anti-Sindbis antibody is cross-protective against S.A.AR 86
infection. TR339 infection of heterozygous IFN-a/bR1/2 mice
yielded similar results (data not shown). These data indicated
that although no clinical signs of infection were evident, TR339
was able to infect both 129 Sv/Ev and heterozygous IFN-a/
bR1/2 mice, eliciting a high-titer protective serum antibody
response. However, in the presence of a functional IFN-a/b
system, the infection was resolved with no overt manifesta-
tions. In startling contrast, IFN-a/bR2/2 mice succumbed to
fatal TR339 infection, with an AST of 2.7 6 0.2 days. TR339
infection appeared to progress rapidly in these animals with
morbidity (weight loss and fur ruffling) observed within 36 h
p.i. By 48 h p.i., the IFN-a/bR2/2 mice had developed severe
conjunctivitis and became increasingly ataxic until death.
Relative susceptibilities of 129 Sv/Ev and IFN-a/bR2/2
mice to TR339 infection. In an attempt to overcome the resis-
tance of IFN-a/bR1/1 adult mice to fatal TR339 infection,
eight background 129 Sv/Ev mice were inoculated s.c. with
approximately 108 PFU of TR339. However, no morbidity or
mortality was recorded among these mice over the 3-week
observation period. Therefore, the 50% lethal dose (LD50) for
TR339 in 129 Sv/Ev mice was .108 PFU, while the LD50 in
IFN-a/bR2/2 mice was ,100 PFU, a difference in susceptibil-
ity of at least 106-fold. These data suggest that a functional
IFN-a/b system is critical for protection of mice from fatal
TR339 infection, since removal of this nonspecific immune
mechanism renders the mice extremely susceptible to infection
even in animals with an otherwise intact adaptive immune
system.
Attenuation of glycoprotein mutant TRSB-R114 in IFN-a/
bR2/2 mice. TRSB-R114 is a cell culture-adapted Sindbis vi-
rus mutant with two mutations in the E2 envelope glycoprotein
that facilitate HS-mediated cell surface attachment (28).
TRSB-R114 is attenuated in neonatal mice compared with
TR339 and replicates to significantly lower titer in all tissues
(28, 61). To investigate the contribution of IFN-a/b to the at-
tenuated phenotype of TRSB-R114, age-matched, adult IFN-
a/bR2/2 mice and background IFN-a/bR1/1 129 Sv/Ev mice
were inoculated s.c. with 100 PFU of TRSB-R114 and then
scored for morbidity and/or mortality at 6-h intervals (Table 1).
No morbidity or mortality was observed in TRSB-R114-in-
fected 129 Sv/Ev mice, and these mice exhibited relatively low
anti-Sindbis virus antibody titers (1:1,783 6 1780) at 3 weeks
p.i., suggesting that replication of TRSB-R114 was reduced
compared to that of TR339. After S.A.AR 86 challenge, 100%
morbidity and 14.3% mortality were observed (Table 1).
TRSB-R114 was also significantly attenuated in IFN-a/bR2/2
mice, causing mild paresis with neurological signs in 3 of 14
mice (21.4%) and death in only 1 (7.1%) at 8 days p.i. The sur-
viving IFN-a/bR2/2 mice responded with high-titer antibody
to Sindbis virus by 3 weeks p.i. (.1:40,960) and were protected
from s.c. challenge with S.A.AR 86. These data indicated
that the glycoprotein mutant TRSB-R114 was highly atten-
uated compared to TR339 even in the absence of a func-
tioning IFN-a/b response and that the induction of anti-
Sindbis virus serum antibody correlated with the extent of
virus replication.
Disseminated replication of TR339 virus in IFN-a/bR2/2
mice. Given the well-characterized role of IFN-a/b in control
of virus replication and dissemination, it was anticipated that
the dramatically increased susceptibility of mice to TR339 in-
fection in the absence of the IFN-a/b system would reflect an
increase in the replication of virus in tissues normally suscep-
tible to virus infection. Therefore, the ability of TR339 to
replicate and disseminate after s.c. inoculation was assessed by
titration of infectious virus from mouse tissues (Fig. 1 and 2).
Randomized groups of 5- to 7-week-old 129 Sv/Ev, IFN-a/
bR1/2, and IFN-a/bR2/2 mice were inoculated s.c. with 100
PFU of TR339 or PBS–1% DCS. At 12, 24, 36, 48, 72, and 96 h
p.i., two (IFN-a/bR1/2) or three (129 Sv/Ev and IFN-a/
bR2/2) mice per group were perfused with PBS–1% DCS to
minimize the contamination of tissues with blood-associated
virus. The titers of infectious virus were determined from se-
rum and the homogenates of multiple tissues. Replication of
TR339 in 129 Sv/Ev mice was restricted, not exceeding 104
PFU/ml or g in any tissue at any time point p.i. Although virus
was detectable 96 h p.i. in the muscle, brain, or spleen of all
TABLE 1. Virulence of TR339 and TRSB-R114 viruses in adult (5- to 7-week-old) IFN-a/bR2/2 mice compared with
















TR339, 100 PFU s.c. 129 Sv/Ev/ 0 (0/3) 0 (0/3) NAd .1:40,960 S.A.AR 86, 103 PFU i.c. 0 (0/3) NA
IFN-a/bR2/2 100 (5/5) 100 (5/5) 2.7 6 0.2 NA NA NA NA
TRSB-R114, 100 PFU s.c. 129 Sv/Ev 0 (0/7) 0 (0/7) NA 1:1,783 (61780) S.A.AR 86, 103 PFU i.c. 14.3 (1/7) 8.0
IFN-a/bR2/2 21.4 (3/14) 7.1 (1/14) 8.0 .1:40,960 S.A.AR 86, 103 PFU i.c. 0 (0/13) NA
PBS 129 Sv/Ev 0 (0/5) 0 (0/5) NA BLDe S.A.AR 86, 103 PFU i.c. 100 (5/5) 7.4 6 1.9
IFN-a/bR2/2 0 (0/5) 0 (0/5) NA BLD S.A.AR 86, 103 PFU i.c. 100 (5/5) 2.2 6 0.4
a The data presented in this table were collected in one experiment. However, the results are representative of four independent experiments, including a total of
40 TR339-infected IFN-a/bR2/2 mice and 38 TR339-infected IFN-a/bR1/1 mice. The ASTs for TR339-infected IFN-a/bR2/2 mice were not significantly different
between experiments, and no morbidity or mortality was observed in any TR339-infected 129 Sv/Ev mice.
b Percent morbidity is defined by weight loss, ruffling of fur, ataxia, paresis, and/or paralysis.
c Percent mortality during a 3-week observation period following primary inoculation or challenge.
d NA, not applicable.
e BLD, below the limit of detection (1:320).
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three 129 Sv/Ev mice, the trend indicated that virus clearance
was underway (Fig. 1 and data not shown). In IFN-a/bR2/2
mice, however, TR339 was able to disseminate rapidly from
the site of inoculation and replicate to a high titer in all of the
tissues tested (Fig. 1 and 2). At between 12 and 24 h p.i.,
infectious virus became detectable in serum and most tissues.
Between 24 and 72 h p.i., the virus titer continued to increase
in serum and all tissues with no evidence of clearance. There-
fore, not only were virus titers in IFN-a/bR2/2 mice much
higher in tissues associated with Sindbis virus replication in
normal adult mice, but high-level virus replication was evident
in all of the tissues examined.
Interestingly, in heterozygous IFN-a/bR1/2 mice interme-
diate virus titers were observed, suggesting a dose dependence
for expression of this subunit of the IFN-a/b receptor. These
titers were still below the threshold level for clinical signs of
disease in the heterozygous mice, however, and clearance of
the virus was not impeded significantly. The significance of
increased replication in some tissues of the IFN-a/bR1/2 mice
(e.g., serum, thymus, lung, heart, liver, and kidney) but not
others (e.g., intestine, stomach, and pancreas) is not yet un-
derstood.
Restricted replication of TRSB-R114 virus in IFN-a/bR2/2
mice. The replication of virulent TR339 and the attenuated
glycoprotein mutant TRSB-R114 were compared in IFN-a/
bR2/2 mice. Three mice per treatment were sacrificed at 72 h
p.i., shortly before TR339-infected mice would have suc-
cumbed to viral infection, and tissues were processed for virus
titration as described previously. Figure 3 demonstrates that
the titers of infectious TRSB-R114 in IFN-a/bR2/2 mice were
reduced in most tissues compared with TR339 titers.
Induction of proinflammatory cytokines during TR339 in-
fection. We have previously observed a strong correlation be-
tween enhanced in vivo replicative potential of TR339, induc-
tion of a systemic inflammatory response syndrome (SIRS),
and virulence defined as decreased AST and increased mor-
tality rate (29). It is likely that the SIRS contributes signifi-
cantly to the proximal cause of death from virulent Sindbis
virus infection. These observations, coupled with the very rapid
disease progression observed in the TR339-infected IFN-a/
bR2/2 mice in this study, prompted the comparison of proin-
flammatory cytokine levels in the serum of the IFN-a/bR2/2,
IFN-a/bR1/2, and 129 Sv/Ev mice (Fig. 4). No significant
induction of proinflammatory cytokines was detectable in 129
FIG. 1. Effects of IFN-a/b on the replication and dissemination of Sindbis virus TR339 in vivo. 129 Sv/Ev IFN-a/bR1/1 mice (E), IFN-a/bR1/2 heterozygous mice
(Œ), and IFN-a/bR2/2 mice (F) were inoculated s.c. with 100 PFU of TR339 and sacrificed at various times p.i., and virus titers from serum (A), brain (B), spleen (C),
and liver (D) were determined. Values represent the geometric mean virus titer (log10 PFU/ml or g) for two (IFN-a/bR1/2) or three (IFN-a/bR2/2 and 129 Sv/Ev)
mice as determined on BHK cells. Datum points are shown 6 the standard deviation (SD), where n 5 3. The lower limit of detection is indicated (broken line).
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Sv/Ev mice. In contrast, IFN-a/bR2/2 mice exhibited elevated
IL-12 p40, IFN-g, TNF-a, and IL-6 in a pattern consistent with
SIRS (2). IL-12 p40 levels peaked at 36 h p.i. at 2,094.6 6
1,795.9 pg/ml (Fig. 4A). A burst of IFN-g was produced in
response to virus infection; this was first detectable 24 h p.i.
(222.8 6 386.0 pg/ml), peaking 6 h later at 8,245.2 6 4,645.1
pg/ml and then declining through 72 h p.i. (Fig. 4B). TNF-a
was first detectable at 24 h p.i. (67.5 6 116.9 pg/ml) and
continued to rise through 72 h p.i. (980.9 6 637.3 pg/ml) (Fig.
4C). IL-6 was produced with similar kinetics, peaking at 36 h
p.i. at 5,607.2 6 3,322.2 pg/ml (Fig. 4D). Although TNF-a and
IL-6 levels had fallen by 48 h p.i., by 72 h p.i., i.e., immediately
prior to the death of these mice, the levels were significantly
elevated again. Induction of TNF-a and IL-6 was sporadically
detectable in heterozygous IFN-a/bR1/2 mice, a finding cor-
relating with slightly increased virus titers in these animals
compared with 129 Sv/Ev controls.
Tissue tropism of TR339 virus in IFN-a/bR2/2 mice. The
presence of high virus titers in widespread tissues of IFN-a/
bR2/2 mice indicated that the IFN-a/b system imposes a
strong restriction on replication and dissemination of TR339
in the adult 129 Sv/Ev mouse. We wished to establish whether
the dramatically increased viral loads observed in the adult
IFN-a/bR2/2 mouse were due to (i) generalized replication
throughout the tissues of these mice or (ii) replication in a
limited subset of cells in which the IFN-a/b system normally
suppresses virus growth. ISH was utilized initially to identify
the sites of virus replication definitively. No virus-specific ISH
signal was observed in any tissue examined from TR339-in-
fected 129 Sv/Ev mice.
Between 12 and 24 h p.i. a specific virus ISH signal became
detectable in the draining lymph nodes (DLNs) and spleens of
IFN-a/bR2/2 mice (Fig. 5A and B). The axial and brachial
LNs were identified as the LNs draining the inoculation site by
FIG. 2. Comparison of TR339 virus titers from multiple tissues at 72 h p.i. 129 Sv/Ev IFN-a/bR1/1 mice (open bars), IFN-a/bR1/2 heterozygous mice (hatched
bars), and IFN-a/bR2/2 mice (solid bars) were inoculated, and tissues were harvested as described in Fig. 1. The values represent the geometric mean virus titer (log10
PFU/ml or g) for two (IFN-a/bR1/2) or three (IFN-a/bR2/2 and 129 Sv/Ev) mice. Datum points are shown 6 the SD, where n 5 3. A 0.5 log10 PFU/ml bar denotes
a value below the limit of detection, i.e., ,1.88 log10 PFU/g for brain, ,2.40 log10 PFU/ml for serum, and ,2.18 log10 PFU/g for all other tissues.
FIG. 3. Replication of TR339 and glycoprotein mutant TRSB-R114 compared in IFN-a/bR2/2 mice. Comparison of TR339 (solid bars) and TRSB-R114
(cross-hatched bars) virus titers in multiple tissues from IFN-a/bR2/2 mice at 72 h p.i. The values represent the geometric mean virus titer (log10 PFU/ml or g) 6 the
SD for three mice.
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the injection of India ink. By ISH, replicating virus was ob-
served, particularly in the subcapsular region of the DLN, with
sporadic signal found in the cells surrounding the follicle. In
the spleen, the virus appeared to be replicating in large dis-
crete cells located in the marginal zone, surrounding the peri-
arteriole lymphocytic sheath (PALS). The location and mor-
phology of these cells allowed their provisional classification to
the macrophage-dendritic-cell (DC) lineage. No infected cells
were detectable at the site of inoculation or in the lung, liver,
kidney, heart, thymus, head, or hindlimb sections at 24 h p.i.
Examination of H&E-stained sections did not reveal any tissue
pathology at this time.
At 72 h p.i., multiple ISH-positive cells of the morphology
described above were found in the spleen (Fig. 5C). Examina-
tion of H&E-stained spleen sections revealed that the clearly
defined follicular architecture normally observed had disinte-
grated significantly by this time, with a notable reduction in
cellularity and morphological evidence of apoptosis at the level
of the light microscope (Fig. 5D). The PALS and B-cell follicle
regions appeared to be most severely affected. The severe
pathology in the spleen was disproportionate to the number of
infected cells, suggesting that some tissue damage may be due
to a cytokine-mediated bystander effect. This speculation is
supported by the presence of high-level IFN-g at this time
point, which previously has been found to contribute to spleen
pathology (58). Similar large discrete cells were infected at 72 h
p.i. in the liver (Fig. 5E), kidney, lung, and thymus (data not
shown). In the liver, a significant proportion of the infected
cells appeared to be sinusoid-lining cells, indicating that they
might be Küpffer cells and/or endothelial cells and not hepa-
tocytes. In addition, at 72 h p.i. extensive virus-specific signal
with associated tissue damage was located in the periosteum
and endosteum of the bones, occasionally extending into ten-
don and fibroblast connective tissue (Fig. 5F). Extensive virus-
specific signal was also associated with the nasal turbinates. In
addition to infected periosteum of the skull, virus-infected cells
also were found lining the lamina propria of the respiratory
and neuroepithelia (Fig. 5G). These cells were tentatively iden-
tified as macrophage-DC-lineage cells based on location and
morphology. Other cells, which appeared to span the neuro-
epithelium, may be olfactory neurons, as has been suggested in
VEE infection (6). Virus-specific signal was observed in the
meninges of all three IFN-a/bR2/2 mice by 72 h p.i. (data not
shown). Thus, replication in the meningeal membranes may
account for the infectious virus titered from CNS tissue, since
ISH analyses indicated that neuroinvasion had occurred in
only one of three mice. In this mouse, an isolated viral lesion
was found in the olfactory bulb, suggesting that neuroinvasion
may occur via the olfactory nerve from the nasal epithelium
(Fig. 5H), as described previously for VEE (6).
Identification of infected cell type(s). Instead of a general-
ized infection of all tissues in the IFN-a/bR2/2 mice, ISH
revealed a preferential infection of cells identified by morphol-
ogy and distribution as resident tissue macrophages and/or
DCs. We have used IHC to identify cells in which Sindbis virus
antigens and surface molecules specific for particular cell types
FIG. 4. Cytokine levels in serum from TR339-infected and mock-infected mice. 129 Sv/Ev IFN-a/bR1/1 mice (E), IFN-a/bR1/2 heterozygous mice (Œ), and
IFN-a/bR2/2 mice (F) were inoculated s.c. with 100 PFU of TR339 (solid line) or with PBS (dashed line), and the serum was harvested at various times p.i. The serum
levels of proinflammatory cytokines were determined by ELISA, as follows: (A) IL-12 p40 (confidence limit of detection, 223.2 pg/ml), (B) IFN-g (confidence limit of
detection, 48.83 pg/ml), (C) TNF-a (confidence limit of detection, 97.66 pg/ml), and (D) IL-6 (confidence limit of detection, 195.31 pg/ml). The values represent the
mean cytokine level for two (IFN-a/bR1/2) or three (IFN-a/bR2/2 and 129 Sv/Ev) mice. Datum points are shown 6 the SD, where n 5 3. The cytokine levels in
PBS-inoculated controls were below the limit of detection except for Fig. 4A, where IL-12 p40 was detectable in 129 Sv/Ev mice at 72 and 96 h p.i.
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were colocalized. Markers included were for macrophages
(Mac-1 and F4/80), DCs (NLDC145, N418, and Mac-1), and B
cells (B220). Overall, IHC appeared to be considerably more
sensitive in detecting virus than was ISH. Since ISH detects
only replicating virus, whereas IHC detects viral antigen, this
difference in sensitivity may be due to the ability of IHC to
detect cells with replicating virus, cells in which replication has
ceased (dead or dying cells) and possibly also trapped or
phagocytosed virus and antigen presented on the cell surface.
However, comparison of IHC and ISH analyses suggested that
a notable subset of Sindbis virus antigen-positive cells were
actively infected.
At 24 h p.i., TR339 antigen could be detected in the DLN,
spleen, and sporadically in the liver of IFN-a/bR2/2 mice. In
the DLN, large cells with dendritic processes were detected
mostly in the subcapsular region but also occasionally extend-
ing between follicles into the medullary region (Fig. 6A). Co-
localization of viral antigen was observed in N418-, NLDC145-,
and/or Mac-1-positive cells (data not shown), confirming the
preliminary placement of infected cells in the macrophage-DC
lineage. In the spleen at 24 h p.i., large macrophage-DC-like
infected cells were detected in circular patterns. Double stain-
ing with a pan-B-cell marker (B220) revealed that these cells
were located in the marginal zone surrounding the PALS,
concentrated on the outer aspect of the B-cell follicle (Fig. 6B).
Marginal zone macrophages have previously been found to
stain with Mac-1 but not F4/80, while F4/80 was abundant on
macrophages in the splenic red pulp (65). N418-positive DCs
are typically found dividing the marginal zone macrophage
layer (1). More recent reports have identified an N418 (bright),
Mac-1 (bright) DC population in the splenic marginal zone
(31, 46). Cells positive for Sindbis virus antigen were identified
in the same region of the splenic marginal zone as cells positive
for Mac-1 (Fig. 6C and D) and N418 (data not shown), sug-
gesting that TR339 may be able to infect these antigen-pre-
senting cells in IFN-a/bR2/2 mice. Limited colocalization with
F4/80 was also observed in the red pulp region (data not
shown). NLDC145 stained a limited number of cells in the
PALS of the spleen but did not colocalize with anti-Sindbis
virus staining (data not shown). No anti-Sindbis virus staining
was found in any of these tissues from 129 Sv/Ev mice.
By 72 h p.i., anti-Sindbis virus staining was considerably
more extensive in both the spleen and the liver of IFN-a/
bR2/2 mice. By this time there appeared to be more dead and
dying cells, in keeping with H&E and ISH analyses. Extensive
colocalization of virus antigen with Mac-1 (Fig. 6E and F)
and/or N418 (data not shown) was observed once again in
spleen, with a more limited F4/80 colocalization outside the
marginal zone in the red pulp (data not shown). Compared
with spleens from 129 Sv/Ev and mock-infected IFN-a/bR2/2
mice, there appears to have been an enormous increase in
N418-positive and Mac-1-positive cells; presumably, this was
due to either upregulation of the cell surface marker or infil-
tration of cells into the infected area. In the liver, viral antigen
colocalization appeared to be with F4/80 (Fig. 6G and H),
although the expression of this marker seemed to have been
downregulated compared with controls (possibly due to the
shutoff of host protein synthesis by the virus infection). Once
again, an increase in Mac-1-positive cells was observed. In 129
Sv/Ev mice IHC analyses of the same tissues from three mice
revealed only two Sindbis virus-positive cells, which were de-
tected in the spleen of one animal (data not shown).
In vitro replication of TR339 in macrophage-DC-like cells.
Peritoneal exudate cells from 129 Sv/Ev or IFN-a/bR2/2 mice,
cultured in vitro, were infected at a high multiplicity (MOI 5
10) with TR339 virus in the presence or absence of anti-IFN-
a/b antibody. When not elicited in vivo with thioglycollate, this
peritoneal cell population includes both immature macro-
phages and DC progenitors (48). Progeny virus harvested from
cell supernatants was barely above the inoculum titer in 129
Sv/Ev cells, whereas more than 106 PFU/ml were produced
from IFN-a/bR2/2 cells (Fig. 7). However, when anti-IFN-a/b
antibody was added to neutralize IFN-a/b released into the
supernatant, TR339 was able to replicate to similar titers in 129
Sv/Ev cells. Thus, exogenous IFN-a/b, released from cultured
peritoneal cells in response to the virus, suppresses Sindbis
virus replication.
DISCUSSION
Viral pathogenesis is the result of a complex interaction
between two dynamic systems, the virus and the host, both of
which change in multiple ways in response to the other. During
the course of a single infection, a virus may change antigeni-
cally to avoid the immune system or, in the longer term, it may
evolve specific mechanisms to thwart the host’s immune sur-
veillance. The host responds to the virus with an impressive
array of nonspecific and adaptive immune systems designed to
slow the infection and eventually clear the virus. The results
presented here attest to the remarkable speed with which non-
specific host defenses are deployed and to the profound effect
of these systems on the apparent cell and tissue tropism of the
virus.
This study of Sindbis virus infection of mice lacking func-
tional receptors for IFN-a/b suggests (i) that the IFN-a/b host
defense mechanism protects adult Sindbis virus-infected ani-
mals from fatal disease, (ii) that priming by low-level endoge-
nous IFN-a/b or early induction of IFN-a/b rapidly induces an
antiviral state in a variety of otherwise-permissive cells and
tissues such that they appear refractory to Sindbis virus infec-
tion, and (iii) that IFN-a/b plays an essential role in the pro-
tection of sentinel macrophage-DC-like cells from Sindbis vi-
rus infection, cells critical for the development of innate and
specific immunity.
IFN-a/b is the primary host defense mechanism against
fatal TR339 infection. Wild-type (nonneuroadapted) Sindbis
virus is limited to a subclinical infection in adult mice, regard-
less of the mouse strain, inoculum dose, or route of adminis-
tration. Following the observation made by Taylor et al. (59)
that the mouse virulence of the original Sindbis virus AR339
isolate was host age dependent, many investigators have at-
tempted to better characterize this phenomenon and thereby
FIG. 5. Histopathological and ISH analyses of tissue sections from TR339-infected IFN-a/bR2/2 mice. Magnification, 3200. ISH analyses were counterstained with
hematoxylin. (A) ISH showing extensive virus replication in large cells of the DLN at 24 h p.i. The B-cell follicle stained more intensely with hematoxylin. (B) ISH
showing virus replication in the spleen at 24 h p.i. Again, the more intensely stained region is the follicle with central arteriole. (C) ISH analysis of the spleen at 72 h
p.i. showing a more widespread virus infection. (D) H&E stain of the same spleen section at 72 h p.i. revealing a severe loss of splenic architecture and reduced
cellularity; the more intensely staining triangular region in the center is the B-cell follicle. (E) ISH showing virus replication in large discrete cells of the liver at 72 h
p.i., some of which have an elongated appearance, suggesting that they may be sinusoid lining cells. (F) ISH analysis of a sagittal section of the right forelimb joint at
72 h p.i. Extensive virus replication is evident in the periosteum of the bone. (G) ISH showing virus replication at 72 h p.i. in the nasal turbinates, both in the lamina
propria and extending into the darker-staining neuroepithelial layer. Virus signal is also seen in the periosteum of the bone. (H) ISH showing an isolated viral lesion
in the olfactory bulb of one mouse at 72 h p.i.
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FIG. 6. IHC analyses of tissue sections from TR339-infected IFN-a/bR2/2 mice. Magnification, 3400. (A) Distribution of Sindbis virus antigen in the DLN at 24 h
p.i. (detected by using CY2-conjugated secondary antibody and visualized by using an FITC filter). (B) Spleen at 24 h p.i. costained for Sindbis virus antigen (CY2)
and B-cell marker, B220 (Texas red). Micrographs were taken with FITC and Texas red filters superimposed to demonstrate localization of Sindbis virus antigen in
the splenic marginal zone surrounding B-cell follicle. Panels C and D represent TR339-infected spleen, at 24 h p.i., costained for Sindbis virus antigen (CY2) and
macrophage marker, Mac-1 (Texas red), respectively. Cells on which virus antigen and Mac-1 colocalize are indicated with paired arrows. Panels E and F show
anti-Sindbis (CY2) and Mac-1 (Texas red) costaining, respectively, in the spleen at 72 h p.i. Extensive colocalization of signal is evident, as indicated by paired arrows,
and the tissue appears to be severely damaged in keeping with ISH and H&E data. Panels G and H show colocalization of Sindbis virus antigen (CY2) and the Küpffer
cell marker, F4/80 (Texas red), in virus-infected liver at 72 h p.i.
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understand the attenuation of Sindbis virus in adult mice. It
has been suggested that the increased resistance of adult mice
to Sindbis virus infection might be due to reduced receptor
abundance (25, 63), complement-mediated inactivation (21),
macrophage clearance (20), and/or resistance of infected neu-
rons to apoptosis (e.g., reference 19). In this study, we have
characterized an essential role for the IFN-a/b system in the
protection of adult mice from fatal Sindbis virus infection.
Mortality studies comparing adult IFN-a/bR1/1 129 Sv/Ev
mice with IFN-a/bR2/2 mice, which are genetically unable to
respond to IFN-a/b, demonstrated the importance of IFN-a/b
in controlling TR339 infection. IFN-a/bR2/2 mice were more
than 106-fold more susceptible to fatal TR339 infection than
129 Sv/Ev mice, with s.c. LD50 values of ,100 and .10
8 PFU,
respectively. Other studies with either IFN-a/b-defective mice
or anti-IFN-a/b antibody have demonstrated a protective role
for IFN-a/b in infections with other viruses, including Theiler’s
virus (12), vesicular stomatitis virus (VSV) (57), influenza virus
(13), measles virus (36), VEE (15, 17), and SFV (22, 37).
However, few viruses have shown such a complete dependence
on this nonspecific immune mechanism for host survival. This
is in keeping with the especially acute sensitivity of Sindbis
virus to the effects of IFN-a/b in vitro (41, 43; W. B. Klimstra
and R. E. Johnston, unpublished observations). Whereas
TR339 replication and dissemination were severely restricted
in 129 Sv/Ev mice, in IFN-a/bR2/2 mice this virus rapidly
disseminated beyond the site of inoculation, established a high-
titer serum viremia, and seeded a systemic infection in distal
tissues. The enormous differential in early virus replication
created by ablating the IFN-a/b receptor suggests that IFN-
a/b normally restricts early virus replication and spread from
the inoculation site very effectively through an autocrine
and/or paracrine mechanism. Tissues beyond the site of inoc-
ulation may be primed for a rapid antiviral response by low-
level endogenous IFN-a/b or may be inherently permissive for
virus replication but become refractory through the systemic
action of IFN-a/b. Alternatively, permissive distal tissues may
remain largely unavailable to the virus under conditions of low
or absent viremia.
In IFN-a/bR2/2 mice inoculated s.c. with TR339, the virus
presumably spreads locally by infecting permissive cells at the
site of inoculation, while simultaneously being carried to the
DLN either as free virus or in migratory Langerhans’ cells or
macrophages that have phagocytosed virus and/or become in-
fected by 24 h p.i. Several alphaviruses have previously been
shown to replicate within regional LNs following peripheral
inoculation, thereby amplifying the serum viremia, including
SFV (52), Ross River virus (42, 53), Getah virus (30), and VEE
(16). It has recently been demonstrated that replication of
VEE in the DLN occurs primarily in cells of the DC lineage
(33). A similar tropism has not previously been demonstrated
in Sindbis virus-infected mice. However, in the absence of an
IFN-a/b response, TR339 spread from the site of inoculation
to the DLN by 24 h p.i. and replicated in cells of macroph-
age-DC lineage. This suggested that Sindbis virus may infect
such cells in normal mice but that replication is either pre-
vented or rapidly suppressed by the IFN-a/b response.
A primary viremia, established by between 12 and 24 h p.i.,
facilitates the rapid systemic dissemination of virus to other
permissive tissues by 24 to 36 h p.i. The majority of viruses
entering the circulation will be trafficked via the splenic artery
to the spleen, where particulate antigens are trapped in mac-
rophages and DCs of the marginal zone and red pulp. In the
IFN-a/bR2/2 mice exposure of these cells to virus apparently
results in infection. Virus from the spleen likely enters the liver
via the hepatic portal vein and again appears to infect cells
designed to capture antigen: sinusoid-lining Küpffer cells
and/or interstitial macrophage-DC-like cells. Infected cells in
other tissues, including the kidney, thymus, lung, and respira-
tory and neuroepithelium, also appear to be macrophage-DC-
like by morphological and locational criteria.
Role of IFN-a/b in attenuation of fatal Sindbis virus infec-
tion with increasing host age or virus mutation. In common
with some other members of the Alphavirus genus, the out-
come of infection with Sindbis virus is strongly dependent on
the age and developmental stage of the host (59). In a short
time-span between 5 and 11 days of age, mice abruptly acquire
resistance to fatal Sindbis virus infection. The mortality rate
falls to zero and, unless the virus has been experimentally
neuroadapted, Sindbis virus is avirulent in adult mice regard-
less of virus strain, dose, or route of inoculation (reviewed in
reference 26). In neonatal mice, s.c. inoculation of TR339 is
rapidly fatal, causing ataxia, paresis, and death by 72 h p.i. (29).
The infection is characterized by widespread and extensive
virus replication, most notably in the dermis of the skin, fibro-
blast connective tissue, and skeletal muscle, disseminating to
the CNS shortly before death. Simultaneously, induction of an
SIRS occurs with significantly elevated levels of proinflamma-
tory cytokines IFN-a/b, IFN-g, TNF-a, and IL-6.
The development of an effective IFN-a/b system is likely to
be an important factor in the acquisition of age-related resis-
tance to fatal Sindbis virus infection, as suggested by several
observations. First, the lack of an effective IFN-a/b response in
adult animals is a major factor in determining adult resistance
to Sindbis infection. Second, the replication of Sindbis virus to
a high titer in neonatal mice in the face of an IFN-a/b response
on the order of 106 IU/ml of serum (29), combined with the
exquisite sensitivity of Sindbis virus to an IFN-a/b-induced
antiviral state in vitro, suggests that the IFN-a/b system may be
ineffective in the neonate. Third, there are at least superficial
similarities between the pathogenesis of TR339 in adult IFN-
a/bR2/2 and neonatal outbred mice, including extensive virus
replication, induction of an SIRS-like cytokine profile, and
rapid mortality. However, an age-dependent reduction in the
permissivity of certain key tissues (including muscle, fibroblast
connective tissue, skin, and CNS) clearly occurs in adults even
FIG. 7. Effects of IFN-a/b on TR339 replication in primary cell cultures.
Primary peritoneal macrophage cultures were infected with TR339 virus (MOI 5
10), and titers of progeny virus released into the supernatant were determined.
Virus growth curves were determined in cells harvested from IFN-a/bR2/2 mice
(F, n 5 3) and 129 Sv/Ev IFN-a/bR1/1 mice (E, n 5 3). Parallel growth curves
were determined in the presence of 8,000 neutralizing U of anti-IFN-a/b anti-
serum in both IFN-a/bR2/2 mice (Œ, n 5 2) and 129 Sv/Ev IFN-a/bR1/1 mice
(‚, n 5 2). Values represent the geometric mean virus titer (log10 PFU/ml). Data
points are shown 6 the SD, where n 5 3.
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in the absence of an effective IFN-a/b response. Conversely, in
neonatal animals TR339 infection of the liver, kidney, and
spleen was limited to occasional ISH-positive cells (29). The
ability of Sindbis virus to infect cells in the DLN of neonatal
mice has not been investigated. Thus, although potentiation of
the IFN-a/b system may play an important role in the acqui-
sition of age-dependent resistance to infection, as suggested
above, it is not likely to be the sole determinant of age-depen-
dent attenuation. We conclude from these observations that
additional factors, which remain to be identified, are acting in
concert with a more effective IFN-a/b response to restrict the
replicative potential of TR339 (and other Sindbis virus strains)
with increasing host age.
The attenuated glycoprotein mutant, TRSB-R114, was
adapted to growth in cell culture by selection for rapid pene-
tration on BHK cells. Unlike TR339, TRSB-R114 attaches
efficiently to cells by a cell surface HS-dependent binding in-
teraction (28). We believe that the attenuated phenotype dis-
played by TRSB-R114 in neonatal mice compared with TR339
results, at least in part, from the nonproductive binding of this
virus to glycosaminoglycans in the extracellular matrix, block-
ing infection and inhibiting dissemination (28). Although this
virus was significantly more virulent in adult IFN-a/bR2/2
mice than in 129 Sv/Ev controls, it remained attenuated rela-
tive to TR339 and replicated much less efficiently. Thus, there
appears to be a replication threshold for virulence. Provided
that replication remains below this threshold when the specific
immune response begins to clear the virus, the mice survive.
Any mechanism which restricts replication or spread of the
virus in adult animals is likely to act together with a fully
functional IFN-a/b system to efficiently localize and clear the
infection.
Role of IFN-a/b in determining apparent tissue tropism.
The results of this study and others (13, 36) suggest that the
apparent virus tissue and cell tropism may be IFN-a/b depen-
dent. Within hours, if not minutes, of virus infection, the host
is physiologically changed from its state at the time of infec-
tion, and the primary mediators of these changes are cytokines
such as IFN-a/b induced in virus-infected cells. Such mediators
can act locally at the site of infection to limit virus replication
and hence spread to other tissues. Alternatively, they can act
systemically to confer an antiviral refractory state on distant
tissues. In either case, failure of a given tissue to evidence virus
replication is not necessarily a function of its innate permis-
siveness or nonpermissiveness for the virus.
Recent studies have demonstrated that, although many cell
types produce IFN-a/b upon stimulation with various agents in
vitro, the main IFN-a/b-producing cells during a virus infec-
tion in vivo are cells of the macrophage-DC lineage, including
leukocytes in the DLN (49), marginal metallophilic and mar-
ginal zone macrophages in the spleen (10, 11), and DC pre-
cursors in the blood (55). The presence of double-stranded
RNA replicative intermediates of influenza virus induces the
IFN-a/b-mediated maturation, activation, and protection of
DC in vitro (5). These reports are in keeping with our finding
that the IFN-a/b system appears to govern the susceptibility of
cells of the macrophage-DC lineage to productive infection by
Sindbis virus. In contrast to the cell tropism evident in normal
animals, the absence of a functional IFN-a/b response was
associated with infection of cells of the macrophage-DC lin-
eage throughout the mouse. The presence of large numbers of
infected splenic marginal zone cells, liver Küpffer cells, and
interstitial DCs in IFN-a/bR2/2 mice suggests that IFN-a/b is
normally responsible for protecting these cells from infection.
Therefore, these results have highlighted an important protec-
tive function for IFN-a/b, since the location of macro-
phage-DC lineage cells and their ability to take up particulate
antigens predisposes these critical cells of the immune system
as primary targets for virus infection (reviewed in reference
27). Interestingly, a similar pattern of infection and uptake in
the marginal zone of the spleen has been shown for a number
of other viruses, including dengue (4), lymphocytic choriomen-
ingitis virus (51), VSV (7), Pichinde (38), and VEE viruses (16).
There is considerable evidence that even though the virus
has access to cells of the macrophage-DC lineage in normal
mice, replication of the virus is severely restricted in these cell
types. Previous Sindbis virus studies identified viral antigens in
adherent cells of the DLN, without evidence of virus replica-
tion (18). Hackbarth et al. (20) showed that radiolabeled Sind-
bis virus particles introduced intracardially are cleared from
the circulation by antigen-presenting cells of the splenic mar-
ginal zone and reticuloendothelial cells of the liver, either via
virus-mediated entry or by phagocytosis. By ISH, we detected
virus replication sporadically in the spleen and liver of normal
outbred neonatal mice (29) and not at all in the spleen or liver
of normal adult mouse. When 129 Sv/Ev mice were inoculated
s.c. with 100 PFU of TR339, the virus was not detectable in the
DLN 24 h p.i., and preliminary experiments simulating a serum
viremia in 129 Sv/Ev mice by intravenous inoculation of 108
PFU of TR339 revealed no detectable infection of splenic
marginal zone cells. Nevertheless, we propose that these cells
in fact are infected in normal animals but that a paracrine
and/or autocrine IFN-a/b response suppresses virus replica-
tion and renders such infections abortive. Peritoneal macro-
phages cultured from 129 Sv/Ev mice appeared to be nonper-
missive for TR339, whereas these same cells were clearly
permissive in the presence of antibody which neutralizes ex-
tracellular IFN-a/b or in analogous cells isolated from IFN-a/
bR2/2 mice.
Proinflammatory cytokines IL-12, IFN-g, TNF-a, and IL-6
are typically induced during gram-negative bacterial sepsis or
in response to bacterial endotoxin in an SIRS. Relatively little
is known about the function and control of these cytokines in
viral infection (3). During the early local inflammatory re-
sponse to virus infection, IL-12 is produced primarily from
activated macrophages and DCs, inducing migration and mat-
uration (5, 8, 9, 35). IL-12 induces the production of IFN-g and
TNF-a, as well as activating macrophages, T cells, and NK
cells. However, the induction of IL-12, as well as resultant
IFN-g, is controlled during virus infection by IFN-a/b (8).
Thus, IL-12 induction observed in TR339 infection of IFN-a/
bR2/2 mice (and, secondary to that, induction of the other
proinflammatory cytokines IFN-g, TNF-a, and IL-6) may be
the direct result of viral replication in cells of this lineage in the
absence of IFN-a/b regulation.
The results of these studies of Sindbis infection in IFN-a/
bR2/2 mice have provided several novel insights into the early
control of virus replication. First, even in the presence of a
completely functional adaptive immune response, it is the IFN-
a/b system which is primarily responsible for protection of
adult mice from fatal Sindbis virus infection. Second, it is
possible that the effectiveness of the IFN-a/b system increases
with the age of the animal and that this is at least partially
responsible for age-related resistance to Sindbis virus infec-
tions. Finally, the similarities observed between the pathogen-
esis of TR339 infection in adult IFN-a/bR2/2 mice and VEE
infection of normal mice (6, 16) suggest that the apparent
tissue tropism differences observed between these alphaviruses
are, at least in part, determined by differential sensitivity to
IFN-a/b and not entirely or even predominantly by differences
in cell-specific targeting directed by the virus envelope glyco-
proteins. Sequence differences in the noncoding regions and
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nonstructural proteins may confer the relative resistance of
VEE to the effects IFN-a/b, allowing this virus to exhibit a
lymphotropic phase in adult mice. Therefore, IFN-a/b may be
influencing the tissue tropism of Sindbis virus by limiting its
access to potentially permissive cells and making otherwise
permissive cells nonpermissive for virus replication. Conse-
quently, notions of viral tissue tropism may require revision to
account for the early effects of IFN-a/b: rapid establishment of
an antiviral state in local and distant cells prior to dissemina-
tion as well as the suppression of viral replication in already-
infected cells.
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